Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128873) titled 'Construction and Validation of a Prognostic Judgment System for End-Stage Heart Failure Assisted by AI Intelligent Technology' on July 27.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Fuzhou University Affiliated Provincial Hospital
Condition:
End-stage heart failure
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Observation group:1550;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334848
Published by HT Digital Content Services with permission from Health Daily Di...